1.Early Experience Using a Left Atrial Appendage Occlusion Device in Patients with Atrial Fibrillation.
Yung Ly KIM ; Boyoung JOUNG ; Young Keun ON ; Chi Young SHIM ; Moon Hyoung LEE ; Young Hoon KIM ; Hui Nam PAK
Yonsei Medical Journal 2012;53(1):83-90
PURPOSE: Atrial fibrillation (AF) is one of the major risk factors for ischemic stroke, and 90% of thromboembolisms in these patients arise from the left atrial appendage (LAA). Recently, it has been documented that an LAA occlusion device (OD) is not inferior to warfarin therapy, and that it reduces mortality and risk of stroke in patients with AF. MATERIALS AND METHODS: We implanted LAA-ODs in 5 Korean patients (all male, 59.8+/-7.3 years old) with long-standing persistent AF or permanent AF via a percutaneous trans-septal approach. RESULTS: 1) The major reasons for LAA-OD implantation were high risk of recurrent stroke (80%), labile international neutralizing ratio with hemorrhage (60%), and 3/5 (60%) patients had a past history of failed cardioversion for rhythm control. 2) The mean LA size was 51.3+/-5.0 mm and LAA size was 25.1x30.1 mm. We implanted the LAA-OD (28.8+/-3.4 mm device) successfully in all 5 patients with no complications. 3) After eight weeks of anticoagulation, all patients switched from warfarin to anti-platelet agent after confirmation of successful LAA occlusion by trans-esophageal echocardiography. CONCLUSION: We report on our early experience with LAA-OD deployment in patients with 1) persistent or permanent AF who cannot tolerate anticoagulation despite significant risk of ischemic stroke, or 2) recurrent stroke in patients who are unable to maintain sinus rhythm.
Aged
;
Anticoagulants/contraindications
;
Atrial Appendage/*physiopathology
;
Atrial Fibrillation/epidemiology/*physiopathology/*surgery
;
Humans
;
Male
;
Middle Aged
;
Risk Factors
;
*Septal Occluder Device
;
Stroke/epidemiology/*prevention & control
;
Treatment Outcome
;
Warfarin/contraindications
2.Application of Mimics three-dimensional imaging in percutaneous left atrial appendage closure with Watchman system.
Dong YANG ; Zhao XU ; Yiqun ZHANG ; Yanhong LUO ; Juhong ZHANG ; Yigang WANG ; Brendan GUNALINGAM ; Xingwei ZHANG
Chinese Journal of Cardiology 2015;43(4):352-357
OBJECTIVEThe three-dimensional (3D) structure of left atrial appendage (LAA) in atrial fibrillation patients were reconstructed by Mimics 3D imaging system, aiming at guiding for selection of both the size and location of the closure devices and making preliminary risk assessment of LAA closure with Watchman system.
METHODSInclusion criteria were: ten voluntary patients with both atrial fibrillation and indication for LAA closure aging from 40 to 85 years old with contraindication for oral anticoagulants or unwillingness to take long-term oral anticoagulation therapy from May to December 2014. 3D reconstruction of LAA was preoperatively made by Mimics 3D imaging system. With the Mimics 3D reconstruction model and the results of both transesophageal echocardiography (TEE) and LAA radiography, the size and location for the closure device were chosen. The devices were planted at the ostium of the LAA.
RESULTSTen atrial fibrillation patients were enrolled (average age: (66.3±11.9) years old) and all successfully implanted with the Watchman LAA closure devices. Nine of them were with non-valvular atrial fibrillation with average CHADS2-VAS score (3.2±1.7) and HAS-BLED score (2.7±1.6). The rest one was a valvular atrial fibrillation patient with the history of the percutaneous balloon mitral valvuloplasty (PBMV) without surgical indications of mitral valve replacement (MVR). There was no blood leakage around the device by regular postoperative TEE and LAA radiography examinations. There were no complications of bleeding, embolism, or stroke through both at peri-operative period and at 1 month follow-up post procedure.
CONCLUSIONPreoperative Mimics 3D reconstruction of LAA by Mimics 3D imaging system among atrial fibrillation patients provides essential information guiding the successful LAA closures.
Adult ; Aged ; Aged, 80 and over ; Anticoagulants ; Atrial Appendage ; surgery ; Atrial Fibrillation ; surgery ; Cardiac Surgical Procedures ; Contraindications ; Echocardiography, Transesophageal ; Embolism ; Humans ; Imaging, Three-Dimensional ; Middle Aged ; Prostheses and Implants ; Prosthesis Implantation ; Stroke ; Treatment Outcome